Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
ViewAttendees 1

BOAF6 - Is Pharmacometrics limited by the industry settings?

Wednesday, November 13, 2024
1:45 PM – 3:15 PM MST
Location: Kaibab & Lantana

Disclosure(s):
Nieves Velez de Mendizabal, PhD: No financial relationships to disclose
Stacey Tannenbaum, PhD, FISoP: No financial relationships to disclose
Ana Ruiz, PharmD, PhD: No financial relationships to disclose
Julia Korell, PhD: Boehringer Ingelheim Pharmaceuticals, Inc.: Employment (Ongoing)
Joga Gobburu, PhD MBA: Pumas-AI Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Vivpro Corp: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Peter Bonate, PhD: Astellas: Employment (Ongoing)

Presentations:

  • 1:45 PM – 3:15 PM MST
    Panel Discussion

    Panelist: Ana Ruiz, PharmD, PhD – Gilead Sciences

    Panelist: Julia Korell, PhD (she/her/hers) – Metrum Research Group

    Panelist: Gemma Dickinson, PhD (she/her/hers) – Eli Lilly and Company

    Panelist: Joga Gobburu, PhD MBA (he/him/his) – University of Maryland

    Panelist: Peter Bonate, PhD – Executive Director at Astellas/ Editor-in-Chief, JPKPD